Sutent Unión Europea - español - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Sunitinib Accord Unión Europea - español - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

SUNITINIB MYLAN 12,5 MG CAPSULAS DURAS EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sunitinib mylan 12,5 mg capsulas duras efg

mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 12,5 mg - sunitinib 12,5 mg - sunitinib

SUNITINIB MYLAN 25 MG CAPSULAS DURAS EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sunitinib mylan 25 mg capsulas duras efg

mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 25 mg - sunitinib 25 mg - sunitinib

SUNITINIB MYLAN 50 MG CAPSULAS DURAS EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sunitinib mylan 50 mg capsulas duras efg

mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 50 mg - sunitinib 50 mg - sunitinib

SUNITINIB DR. REDDYS 12,5 MG CAPSULAS DURAS EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sunitinib dr. reddys 12,5 mg capsulas duras efg

reddy pharma iberia s.a. - sunitinib malato - cÁpsula dura - 12,5 mg - sunitinib malato 12,5 mg - sunitinib

SUNITINIB DR. REDDYS 25 MG CAPSULAS DURAS EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sunitinib dr. reddys 25 mg capsulas duras efg

reddy pharma iberia s.a. - sunitinib malato - cÁpsula dura - 25 mg - sunitinib malato 25 mg - sunitinib